长期用糖皮质激素患者的手术与围手术期并发症的预防(2)
参考文献
1 张延龄.围手术期一次剂量糖皮质激素的作用.国外医学外科学分册,2002,30(4):224-225.
2 刘颖斌,彭淑镛,彭承宏,等.长期应用糖皮质激素患者术后吻合口瘘的预防.中国实用外科杂志,2001,21(6):339-340.
3 刘家奇.长期应用激素患者合并外科疾病的手术治疗和体会.广西医学,1987,(6):293-295.
4 王卫民,张澜,张静涛,等.长期应用肾上腺糖皮质激素患者的围手术期处理.中华腹部疾病杂志,2003,3(8):594-595.
5 Axelrod L.Perioperative management of patients treated with glucocorticoids.Endocrinol Metab Clin North Am,2003,32(2):367-383.
6 Reding R,Michel LA,Donckier J,et al.Surgery in patients on long-term steroid therapy:a tentative model for risk assessment.Br J Surg,1990,77(10):1175-1178.
7 Hermus AR,Zelissen PM.Diagnosis and therapy of patients with adrenocortical insufficiency.Ned Tijdschr Geneeskd,1998,142(17):944-949.
8 Bruewer M,Utech M,Rijcken EJ,et al.Preoperative steroid administration:effect on morbidity among patients undergoing intestinal bowel resection for Crohn disease.World J Surg,2003,27(12):1306-1310.
9 Jacke J,Bolder U,Herrmann A,et al.long-term risk of gastrointestinal tumor recurrence after postoperative treament with recombinant human growth hormone.J Paraenter Enter Nutr,2000,24(3):140.
10 Post S,Betzler M,von Ditfurth B,Schurmann G,Kuppers P,Herfarth C.Risks of intestinal anastomoses in Crohn’s disease.Ann Surg，1991，213(1):37-42., http://www.100md.com(梁毕科 肖旭波 韩少良 郑晓风)
1 张延龄.围手术期一次剂量糖皮质激素的作用.国外医学外科学分册,2002,30(4):224-225.
2 刘颖斌,彭淑镛,彭承宏,等.长期应用糖皮质激素患者术后吻合口瘘的预防.中国实用外科杂志,2001,21(6):339-340.
3 刘家奇.长期应用激素患者合并外科疾病的手术治疗和体会.广西医学,1987,(6):293-295.
4 王卫民,张澜,张静涛,等.长期应用肾上腺糖皮质激素患者的围手术期处理.中华腹部疾病杂志,2003,3(8):594-595.
5 Axelrod L.Perioperative management of patients treated with glucocorticoids.Endocrinol Metab Clin North Am,2003,32(2):367-383.
6 Reding R,Michel LA,Donckier J,et al.Surgery in patients on long-term steroid therapy:a tentative model for risk assessment.Br J Surg,1990,77(10):1175-1178.
7 Hermus AR,Zelissen PM.Diagnosis and therapy of patients with adrenocortical insufficiency.Ned Tijdschr Geneeskd,1998,142(17):944-949.
8 Bruewer M,Utech M,Rijcken EJ,et al.Preoperative steroid administration:effect on morbidity among patients undergoing intestinal bowel resection for Crohn disease.World J Surg,2003,27(12):1306-1310.
9 Jacke J,Bolder U,Herrmann A,et al.long-term risk of gastrointestinal tumor recurrence after postoperative treament with recombinant human growth hormone.J Paraenter Enter Nutr,2000,24(3):140.
10 Post S,Betzler M,von Ditfurth B,Schurmann G,Kuppers P,Herfarth C.Risks of intestinal anastomoses in Crohn’s disease.Ann Surg，1991，213(1):37-42., http://www.100md.com(梁毕科 肖旭波 韩少良 郑晓风)